because of the widespread long-term clinical use of luteinizing hormone-releasing hormone ( lrh ) agonists , the possibility of antibody development to one of these , ( d-ser- ( butt ) 6 ) lrh ( 1-9 ) nonapeptide-ethylamide ( buserelin ) , has been studied by examining sera from experimental animals and humans receiving long-term agonist-treatment for ability to bind 125i-labelled buserelin .
C0023610
lrh
C0006456
buserelin